The latest biotechnology news | Bio News
covid-19-vaccine-syringe

FDA proposes updating COVID boosters annually

To simplify and streamline the COVID-19 vaccination process while pushing for increased vaccination ...
Read More
climate change pollution smoke environment air quality free image via Unsplash

Carbon removal technology is needed for reaching net zero

Reaching net zero is impossible without more plans and policies to remove carbon ...
Read More
stefan-vladimirov-Q_Moi2xjieU-unsplash

‘Biotechnology holds solutions’ to climate change and food security

Biotech experts at Davos last week agreed that despite facing many challenges, in ...
Read More
BIO-Interim-CEO

BIO’s Interim CEO discusses biotech policy, optimism with industry in Maryland

Rachel King, Interim CEO of the Biotechnology Innovation Organization (BIO), described the organization’s ...
Read More
james-yarema-kdgiNc0sDeI-unsplash

Patent systems for drugs matter – here’s why

The U.S. Patent and Trademark Office (USPTO) and the U.S. Food and Drug ...
Read More
PBM-exclusion

Excluding drugs from coverage helps PBMs keep profits higher

When the largest private insurance companies use their leverage to save on the ...
Read More
Save with Avantor and BIO Business Solutions

EDITORS' CHOICE

Fritz Bittenbender

A conversation with Fritz Bittenbender, new BIO Board Chair

The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More

LATEST NEWS

BIO Events

Startup Stadium: Tezcat Biosciences targets common cancer mutation

A Rat sarcoma (RAS) mutation is an oncogene, a gene that causes cancer when mutated. The RAS is the most commonly mutated oncogene in human ...
Federal Policy

Psoriasis awareness: The condition is more than skin deep

Over 8 million people in the U.S., and 125 million worldwide, live with psoriasis—about 2–3% of the population. Far from being a simple cosmetic condition, ...
Health

BIO 2025: As M&A slows, biotechs need to show good data

M&A in biotech has slowed from its peak in 2023 but there are still deals to be done, especially for companies who can present good ...
BIO Events

BIO 2025: How weight loss drugs are disrupting chronic disease

“Initial weight loss is just the first chapter,” said Mia de Graaf, Deputy Executive Health Editor at Business Insider, “but the real challenge and opportunity ...
BIO Events

BIO 2025: Psychedelics go mainstream – what’s next?

When experts discussed clinical uses of psychedelics two years ago at the 2023 Biotechnology Innovation Organization (BIO) International Convention, there was some interest in separating ...

Welcome, John F. Crowley!

Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.

Federal Policy

State Policy

International

Bio's View

Scroll to Top